ResearcherMedical University of South CarolinaNo recent work listed

Thomas Hendrix Beckham

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6189-6996; OpenAlex author ID A5081175661. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2013: 1 paper

Papers 1

LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria. Co-author DOI 10.1124/jpet.112.199216 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiang Liu · 1 shared paper, 2013 · strength 0.03
- Paper LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria. DOI 10.1124/jpet.112.199216 ↗
Clayton S. Lewis · 1 shared paper, 2013 · strength 0.03
- Paper LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria. DOI 10.1124/jpet.112.199216 ↗
Richard R. Drake · 1 shared paper, 2013 · strength 0.03
- Paper LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria. DOI 10.1124/jpet.112.199216 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.